Bibliographic citations
Zegarra, L., Paucar, M. (2022). Prevalencia de comorbilidades metabólicas en la enfermedad grave o crítica por SARS-CoV-2 en niños y adolescentes: revisión sistemática y metaanálisis [Tesis, Universidad Peruana de Ciencias Aplicadas (UPC)]. http://hdl.handle.net/10757/663423
Zegarra, L., Paucar, M. Prevalencia de comorbilidades metabólicas en la enfermedad grave o crítica por SARS-CoV-2 en niños y adolescentes: revisión sistemática y metaanálisis [Tesis]. PE: Universidad Peruana de Ciencias Aplicadas (UPC); 2022. http://hdl.handle.net/10757/663423
@misc{renati/401503,
title = "Prevalencia de comorbilidades metabólicas en la enfermedad grave o crítica por SARS-CoV-2 en niños y adolescentes: revisión sistemática y metaanálisis",
author = "Paucar Chacon, Maria Clarissa",
publisher = "Universidad Peruana de Ciencias Aplicadas (UPC)",
year = "2022"
}
Introduction: Severe or critical illness due to SARS-CoV-2 in pediatric patients is not frequent and is associated with comorbidities. Identifying the prevalence of metabolic comorbidities in patients with severe or critical illness will allow public health decisions to be made. Objective: To establish the prevalence of metabolic comorbidities in pediatric patients with severe or critical illness due to SARS-CoV-2. Methods: A systematic search was performed on nine databases to find articles published up to August 2021, which reported on the presence of metabolic comorbidities and severe or critical COVID-19 in children and adolescents under 21 years of age. A random effects model meta-analysis was used to estimate prevalences and confidence intervals. Results: 13 studies were included, of which 11 were used for the meta-analysis. In severe or critical illness due to SARS-CoV-2 in children and adolescents, this study found that obesity has a prevalence of 21% (IQ 95% 13 - 30%, 10 studies, 370 patients), overweight has a prevalence of 14% (IC 95% 1 - 36%), diabetes mellitus 1 of 1% (IC 95% 0 - 6%), non-specified diabetes mellitus of 7% (IC 95% 2 - 15%) and other metabolic disease has a prevalence of 2% (IC 95% 0 - 7%). Conclusions: Obesity and overweight were the most prevalent metabolic comorbidity among pediatric patients with severe or critical illness due to SARS-CoV-2.
This item is licensed under a Creative Commons License